← SynDRA
dactinomycin
SynDRA canonical compound SYN0086993 — structure-anchored drug synonym record
| Primary target(s) | POLR2A |
| Mechanism of action | RNA polymerase inhibitor |
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ATXN2
- TDP1
- TARDBP
- SMN1
- PIN1
- NFE2L2
- MBNL1
- MAPT
- MAPK1
- KDM4E
- KDM4A
- HPGD
- GNAS
- GMNN
- GLP1R
- GBA1
- GAA
- EYA2
- EHMT2
- BAZ2B
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ABC3G
- DRD3
- FUS
- G3P
- GPR151
- GSTO1
- PAFA
- PHGDH
- PTBP1
Cross-references
Synonyms
- SR-05000001547
- CHEBI:91853
- HMS2091C17
- Pharmakon1600-00330001
- NSC755841
- CCG-213691
- NSC-755841
- SBI-0206669.P002
- AB01563171_01
- SR-05000001547-1
- SR-05000001547-2
- BRD-A73909368-001-01-5
- 2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxylic acid bis[1-[10,13-dimethyl-2,5,8,11,14-pentaoxo-3,9-di(propan-2-yl)-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-6-yl]ethyl] ester
Look up dactinomycin in the interactive SynDRA portal →